Skip to content
Screener

Dolby Laboratories, Inc. DLB Licensing — Total Revenue

Other product segments

Broadcast
$119.2M+26.5%
Mobile
$94.24M-5.9%
PC
$59.46M+1.8%
Other
$58.39M+6.0%
CE
$40.95M+7.4%
Products and services
$23.39M-0.7%

Similar metrics at other companies

Everspin Technologies logo
MRAMLicensing — Total Revenue
$0-100%
Shake Shack logo
SHAKLicensing revenue — Total Revenue
$14.18M+7.1%
AbCellera Biologics Inc. logo
ABCLLicensing and royalty revenue — Total Revenue
$149K-98.6%
Moderna logo
MRNALicensing and royalty revenue — Total Revenue
$0-100%
Guardant Health logo
GHLicensing and other — Total Revenue
$2.14M+15.3%
Arteris, Inc. logo
AIPLicensing, support and maintenance — Total Revenue
$20.82M+38.0%

Other financials

Income statement

See full
Revenue$395.6M+7.1%
Gross profit$350.9M+5.1%
Operating income$112.9M+4.8%
Net income$94.9M+3.4%
EPS (diluted)$0.99+5.3%

Balance sheet

See full
Cash & equivalents$673.8M-10.2%
Total debt$49.7M+22.9%
Total equity$2.6B+1.7%
Total assets$3.2B+0.6%

Cash flow

See full
Operating cash flow$92.5M-47.1%
CapEx$9.1M+31.4%
Free cash flow$83.4M-50.3%

Valuation

See full
Market cap$5.71B-17.7%
Enterprise value$5.08B-18.2%
P/E23.4×-2.8×
P/S4.2×-1.0×

Profitability

See full
Gross margin87.4%-1.5pp
Operating margin18.5%-2.0pp
Net margin17.9%-1.6pp
FCF margin22.1%-7.5pp

Returns & leverage

See full
Return on equity9.4%-0.9pp
Debt / equity0×0.0×
Current ratio3×-0.1×

Where this comes from

Reported directly by Dolby Laboratories, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Dolby Laboratories, Inc.’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:45 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0001308547-26-000010
Line itemFiscal Quarter Ended / March 27,2026Fiscal Quarter Ended / March 28,2025Fiscal Year-To-Date Ended / March 27,2026Fiscal Year-To-Date Ended / March 28,2025
Revenue:
Licensing$372,245$346,006$692,016$676,485
Products and services23,38523,55550,32050,075
Total revenue395,630369,561742,336726,560
Cost of revenue:
Cost of licensing24,04319,68544,80540,795
Cost of products and services20,68816,15243,13435,816
Total cost of revenue44,73135,83787,93976,611

ITEM 1. UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FAQ

What is Dolby Laboratories, Inc.'s licensing — total revenue?
Dolby Laboratories, Inc. (DLB) reported licensing — total revenue of $372.25M in Q1 2026.
How has Dolby Laboratories, Inc.'s licensing — total revenue changed year-over-year?
Dolby Laboratories, Inc.'s licensing — total revenue increased by 7.6% year-over-year, from $346.01M to $372.25M.
What is the long-term trend for Dolby Laboratories, Inc.'s licensing — total revenue?
Over 4 years (2021 to 2025), Dolby Laboratories, Inc.'s licensing — total revenue has grown at a 0.7% compound annual growth rate (CAGR), from $1.21B to $1.25B.
What does licensing — total revenue mean?
This metric represents the total gross revenue generated from licensing intellectual property, patents, or proprietary technology to third-party manufacturers and partners. It serves as a primary indicator of the market adoption and monetization scale of the company's core technological assets.

Ask your AI about Dolby Laboratories, Inc.'s licensing — total revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude